1.4. Analysis.
Comparison 1: Palivizumab versus placebo or no intervention, Outcome 4: Hospitalisation due to respiratory‐related illness
Comparison 1: Palivizumab versus placebo or no intervention, Outcome 4: Hospitalisation due to respiratory‐related illness